Publications, Pharmaceutical

Healthcare Packaging: The Future of Medical Devices

The connected device industry has changed significantly over the past years and has many benefits as well as developmental challenges.

Essentially connected devices are either add-ons or integrated and choice is primarily driven by cost and sustainability issues. This interview reviews the evolution of connected devices, strategies for improving patient’s health outcomes and broader issues associated with sustainability. Regulatory approvals, reimbursement as well as real world evidence and Digital Therapeutics are recognised goals but poor patient compliance and adherence, management of personal data and adoption of digital healthcare tools are all highlighted as key contributory factors when it comes to the overall challenges of successful adoption of connected devices.

Read the Interview
Author(s): Marcus Bates
16 May 2022

Learn more about Aptar Pharma’s expertise in Digital Health

Find Out More about Aptar Digital Health

This Might Also Be of Your Interest

1 Jul 2021

Using digital therapeutics to improve inhaler use and patient outcomes

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
16 Dec 2020

COVID-19 intensifies need for and uptake of digital healthcare

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Nov 2020

The Need to Scale Up Digital Health in the Post-Covid World

Webinars, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights

Read More
1 Jun 2020

Applying Connectivity to Enhance The Training Standard of Care for Self-Injection

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 2 3 4 5

How Can We Help?

Back To Top